相似文献
1
Cloning and sequence analysis of a Bothrops jararaca cDNA encoding a precursor of seven bradykinin-potentiating peptides and a C-type natriuretic peptide.
Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1189-93. doi: 10.1073/pnas.94.4.1189.
2
Bradykinin-potentiating peptides and C-type natriuretic peptides from snake venom.
Immunopharmacology. 1999 Oct 15;44(1-2):129-35. doi: 10.1016/s0162-3109(99)00119-8.
3
The C-type natriuretic peptide precursor of snake brain contains highly specific inhibitors of the angiotensin-converting enzyme.
J Neurochem. 2003 May;85(4):969-77. doi: 10.1046/j.1471-4159.2003.01743.x.
4
A novel peptide from the ACEI/BPP-CNP precursor in the venom of Crotalus durissus collilineatus.
Comp Biochem Physiol C Toxicol Pharmacol. 2006 Oct;144(2):107-21. doi: 10.1016/j.cbpc.2006.04.006. Epub 2006 Apr 28.
5
cDNA cloning of bradykinin-potentiating peptides-C-type natriuretic peptide precursor, and characterization of the novel peptide Leu3-blomhotin from the venom of Agkistrodon blomhoffi.
Eur J Biochem. 2000 Jul;267(13):4075-80. doi: 10.1046/j.1432-1327.2000.01443.x.
6
Identification of novel bradykinin-potentiating peptides and C-type natriuretic peptide from Lachesis muta venom.
Toxicon. 2005 Jul;46(1):31-8. doi: 10.1016/j.toxicon.2005.03.006.
7
A survey of gene expression and diversity in the venom glands of the pitviper snake Bothrops insularis through the generation of expressed sequence tags (ESTs).
Gene. 2002 Oct 16;299(1-2):279-91. doi: 10.1016/s0378-1119(02)01080-6.
8
Purification and characterization of a kinin-releasing and fibrinogen-clotting serine proteinase (KN-BJ) from the venom of Bothrops jararaca, and molecular cloning and sequence analysis of its cDNA.
Eur J Biochem. 1998 Feb 1;251(3):845-53. doi: 10.1046/j.1432-1327.1998.2510845.x.
9
The molecular cloning of a phospholipase A2 from Bothrops jararacussu snake venom: evolution of venom group II phospholipase A2's may imply gene duplications.
J Mol Evol. 1995 Aug;41(2):174-9. doi: 10.1007/BF00170670.
10
Identification of snake bradykinin-potentiating peptides (BPPs)-simile sequences in rat brain--Potential BPP-like precursor protein?
Biochem Pharmacol. 2015 Aug 1;96(3):202-15. doi: 10.1016/j.bcp.2015.05.012. Epub 2015 Jun 3.
引用本文的文献
1
Variations in "Functional Site" Residues and Classification of Three-Finger Neurotoxins in Snake Venoms.
Toxins (Basel). 2025 Jul 24;17(8):364. doi: 10.3390/toxins17080364.
2
Analysis of the Snake Venom Peptidome.
Methods Mol Biol. 2024;2758:319-329. doi: 10.1007/978-1-0716-3646-6_17.
3
A Review of Rattlesnake Venoms.
Toxins (Basel). 2023 Dec 19;16(1):2. doi: 10.3390/toxins16010002.
4
Snake Venom Components as Therapeutic Drugs in Ischemic Heart Disease.
Biomolecules. 2023 Oct 18;13(10):1539. doi: 10.3390/biom13101539.
5
Extracellular Vesicles from Venom Are Diverse in Structure and Protein Composition and Interact with Mammalian Cells.
Toxins (Basel). 2022 Nov 19;14(11):806. doi: 10.3390/toxins14110806.
6
Two-Dimensional Blue Native/SDS Polyacrylamide Gel Electrophoresis for Analysis of Brazilian Snake Venoms.
Toxins (Basel). 2022 Sep 23;14(10):661. doi: 10.3390/toxins14100661.
7
Differences in PLA Constitution Distinguish the Venom of Two Endemic Brazilian Mountain Lanceheads, and .
Toxins (Basel). 2022 Mar 25;14(4):237. doi: 10.3390/toxins14040237.
8
venom and its components - an overview.
J Venom Res. 2021 May 28;11:26-33. eCollection 2021.
9
A Meta-Analysis of the Protein Components in Rattlesnake Venom.
Toxins (Basel). 2021 May 23;13(6):372. doi: 10.3390/toxins13060372.
10
Tracking the recruitment and evolution of snake toxins using the evolutionary context provided by the genome.
Proc Natl Acad Sci U S A. 2021 May 18;118(20). doi: 10.1073/pnas.2015159118.
本文引用的文献
1
Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin.
Am J Physiol. 1949 Feb;156(2):261-73. doi: 10.1152/ajplegacy.1949.156.2.261.
2
A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA.
Br J Pharmacol Chemother. 1965 Feb;24(1):163-9. doi: 10.1111/j.1476-5381.1965.tb02091.x.
3
The preparation and function of the hypertensin-converting enzyme.
J Exp Med. 1956 Mar 1;103(3):295-9. doi: 10.1084/jem.103.3.295.
4
Cloning and sequence analysis of cDNAs encoding precursors of sarafotoxins. Evidence for an unusual "rosary-type" organization.
J Biol Chem. 1993 Feb 15;268(5):3052-5.
5
Physiology of natriuretic peptides.
J Intern Med. 1994 Jun;235(6):527-41. doi: 10.1111/j.1365-2796.1994.tb01261.x.
6
Converting enzyme inhibitors in cardiovascular therapy: current status and future potential.
Cardiovasc Res. 1994 Feb;28(2):146-58. doi: 10.1093/cvr/28.2.146.
7
Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
Br J Pharmacol. 1994 Jan;111(1):238-44. doi: 10.1111/j.1476-5381.1994.tb14050.x.
8
Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
Pharmacol Rev. 1995 Mar;47(1):25-49.
9
Molecular modeling of the substrate specificity of prohormone convertases SPC2 and SPC3.
J Biol Chem. 1995 Jun 2;270(22):13277-84. doi: 10.1074/jbc.270.22.13277.
10
Effect of stretching on the sensitivity of the guinea pig ileum to bradykinin and on its modification by bradykinin potentiating peptides.
Eur J Pharmacol. 1981 Apr 9;70(4):551-8. doi: 10.1016/0014-2999(81)90366-6.
Zotero 插件